Physician profile
Prithvi Murthy
NPI 1629422274
$31,709.73
in general payments reported to CMS, 2019-2025
25 companies · $27K in 2025
The $27K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2024: $4,899 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Honoraria: $2,500 · Food and Beverage: $2,380 · Travel and Lodging: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,983.66 |
| Honoraria | $2,500.00 |
| Food and Beverage | $2,379.70 |
| Travel and Lodging | $731.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $11,716.39 | 2025 | |
| Janssen Biotech, INC. | $10,893.03 | 2024-2025 | Erleada, Akeega, Balversa |
| Immunitybio, INC. | $2,515.66 | 2025 | |
| Ferring Pharmaceuticals INC. | $2,316.87 | 2024 | Adstiladrin |
| Telix Pharmaceuticals | $1,863.30 | 2024 | |
| Intuitive Surgical, INC. | $1,266.45 | 2024-2025 | |
| Coloplast Corp | $195.53 | 2024 | |
| Calyxo, INC. | $173.24 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $159.37 | 2024-2025 | Orgovyx, Gemtesa |
| Baxter Healthcare | $114.54 | 2021 | |
| Procept Biorobotics Corporation | $62.02 | 2025 | |
| Boston Scientific Corporation | $52.50 | 2025 | Lithovue, Rezum Generator |
| Merck Sharp & Dohme LLC | $51.16 | 2025 | Keytruda, Keytruda Qlex, Bridion |
| Urogen Pharma, INC. | $47.73 | 2025 | |
| Astellas Pharma US INC | $43.75 | 2025 | Xtandi |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $40.54 | 2025 | |
| Smith+Nephew, INC. | $35.18 | 2025 | Stravix |
| Olympus America INC. | $32.49 | 2025 | Itind System |
| Laborie Medical Technologies Corp. | $27.66 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Lantheus Medical Imaging, INC. | $21.15 | 2024 | |
| Bluewind Medical | $16.92 | 2024 | Revi |
| Pfizer INC. | $16.83 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.62 | 2024 | |
| Myriad Genetic Laboratories, INC. | $15.43 | 2024 | Myrisk |
| Agiliti Surgical, INC. | $15.37 | 2024 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu, Endocare Cryocare Cs System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prithvi Murthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.